Ras/NN
oncogene/NN
transformation/NN
of/IN
human/JJ
B/NN
lymphoblasts/NNS
is/VBZ
associated/VBN
with/IN
lymphocyte/NN
activation/NN
and/CC
with/IN
a/DT
block/NN
of/IN
differentiation/NN
./.

The/DT
p21ras/NN
small/JJ
GTP/NN
binding/NN
proteins/NNS
participate/VBP
in/IN
signal/JJ
transduction/NN
from/IN
cell/NN
surface/NN
receptors/NNS
and/CC
affect/VB
neoplastic/JJ
transformation/NN
and/CC
development/NN
in/IN
many/JJ
different/JJ
cell/NN
types/NNS
./.
=====
In/IN
the/DT
present/JJ
study/NN
,/,
we/PRP
examined/VBD
the/DT
relationship/NN
between/IN
ras/NN
transformation/NN
and/CC
differentiation/NN
of/IN
human/JJ
B/NN
lymphocytes/NNS
./.
=====
We/PRP
show/VBP
that/IN
the/DT
constitutive/JJ
expression/NN
of/IN
the/DT
T24/NN
Ha-ras/NN
oncogene/NN
in/IN
EBV-immortalized/JJ
B/NN
lymphoblasts/NNS
was/VBD
associated/VBN
with/IN
the/DT
induction/NN
of/IN
the/DT
interleukin/NN
2/CD
receptor/NN
alpha/NN
subunit/NN
,/,
with/IN
an/DT
impaired/JJ
immunoglobulin/NN
gene/NN
expression/NN
,/,
altered/JJ
adhesion/NN
properties/NNS
and/CC
increased/VBN
survival/NN
in/IN
serum-free/JJ
medium/NN
./.
=====
Since/IN
induction/NN
of/IN
the/DT
IL-2/NN
receptor/NN
alpha/NN
subunit/NN
is/VBZ
a/DT
hallmark/NN
of/IN
lymphocyte/NN
activation/NN
,/,
we/PRP
suggest/VBP
that/IN
p21ras/NN
naturally/RB
triggers/VBZ
B/NN
cell/NN
activation/NN
./.
=====
The/DT
ras-transformed/JJ
lymphocytes/NNS
displayed/VBD
a/DT
fully/RB
functional/JJ
IL-2r/NN
,/,
as/IN
assessed/VBN
by/IN
c-fos/NN
induction/NN
following/VBG
treatment/NN
with/IN
IL-2/NN
;/:
nevertheless/RB
,/,
they/PRP
were/VBD
not/RB
growth/NN
stimulated/VBN
by/IN
this/DT
lymphokine/NN
./.
=====
The/DT
decreased/VBN
expression/NN
of/IN
immunoglobulin/NN
genes/NNS
indicates/VBZ
that/IN
the/DT
ras/NN
oncogene/NN
blocks/VBZ
terminal/JJ
differentiation/NN
to/TO
plasma/NN
cells/NNS
,/,
possibly/RB
by/IN
inhibiting/VBG
the/DT
activity/NN
of/IN
lymphocyte-specific/JJ
transcription/NN
factors/NNS
./.
=====
Somewhat/RB
unexpectedly/RB
,/,
the/DT
constitutive/JJ
p21ras/NN
activity/NN
did/VBD
not/RB
cause/VB
an/DT
increased/VBN
DNA/NN
binding/NN
of/IN
transcription/NN
factors/NNS
PEA1/NN
(/(
AP1/NN
)/)
,/,
PEA3/NN
,/,
Oct-2/NN
or/CC
NF-kB/NN